Five Advantages of Veranex’s Quality Management Systems
Our approach to Quality Management ensures that we’re always speaking the same language.
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
6 min read
Bill Croisetiere
:
Nov 5, 2025 10:36:34 AM
You've spent months perfecting your medical device concept. The prototype works beautifully in testing. Your team is energized, regulatory strategy is taking shape, and clinical trials are on the horizon. So why are seasoned manufacturing experts urging you to pump the brakes?
The answer lies in a critical but often underappreciated step that can make or break your transition from prototype to scalable manufacturing: medical device process validation.
Process validation is the systematic approach to ensuring that a manufacturing process consistently produces medical devices that meet predetermined specifications and quality requirements. Unlike product testing, which verifies the final device, process validation ensures the manufacturing steps themselves are reliable and repeatable through the execution of Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols.
When most people think about "design for manufacturability," they picture engineers in front of CAD systems, optimizing screw types and minimizing part counts. While that's certainly part of it, there's a more fundamental challenge lurking beneath the surface.
The real question isn't just whether your device can be manufactured. It's whether it can be manufactured consistently, reliably, and by anyone who follows your process. This distinction becomes critical when you consider that manufacturing hiccups don't just delay timelines; they can derail entire clinical programs.
Consider this real-world scenario: A micro-dosing syringe that worked perfectly when Paul assembled it on Monday but failed when Chris assembled identical units on Tuesday. Same specifications, same materials, same assembly instructions. The difference? The gluing and curing processes had never been properly specified, validated, or challenged. Success depended entirely on individual skill and intuition.
This is precisely the type of manufacturing vulnerability that medical device process validation is designed to eliminate.
Most medical device development follows a structured phase-gate approach, moving through research and concept generation (Phase 0), concept development and feasibility (Phase 1), detailed design (Phase 2), design verification (Phase 3), design validation and manufacturing transfer (Phase 4), and finally production support (Phase 5).
Here's where things go wrong: Companies often leave Phase 1 thinking they're ready for Phase 5. They have a working prototype and assume manufacturing is simply a matter of making more of them. What they're missing are the critical phases 2-4, where the real work of manufacturing transfer happens.
This gap becomes expensive quickly. Process variation and process drift are real phenomena. You might manufacture good product one week and failing product the next, with no clear understanding of what changed. The root cause almost always traces back to what was or wasn't accomplished in those middle phases.

Here's the uncomfortable truth: if you're planning to manufacture only 2,000 units in your first five years, full process validation might require you to build 10,000 units just for validation purposes. The math doesn't work for many early-stage companies.
This doesn't mean you should skip process development entirely. Instead, you might choose to "inspect quality into the product" rather than validate it in, a riskier approach, but sometimes the only practical option given resource constraints.
The key is making this decision consciously, with full awareness of the trade-offs involved, rather than stumbling into it accidentally.
One final consideration: don't be afraid to optimize your design early if it prevents major manufacturing headaches later. For example, if your current design requires assembling five separate components into a subassembly, it might be worth the upfront investment to redesign that as a single injection-molded part.
These decisions become much more expensive to reverse after design freeze, which is why investigating your manufacturing processes before that milestone is so critical.
Process validation isn't glamorous, but it's the difference between a manufacturing process that scales smoothly and one that requires constant firefighting. The investment you make in understanding and validating your processes during phases 2-4 pays dividends when you're ready to scale production.
The companies that get this right don't need fully automated production lines right out of the gate. They need processes that are robust enough that anyone can execute them successfully. Automation can come later, once you understand exactly what you're automating.
When should medical device process validation occur? Process validation activities should begin during Phase 2 (detailed design development) and continue through Phase 4 (design validation and manufacturing transfer). The earlier you start, the more flexibility you have to optimize both design and process.
How much does medical device process validation cost? Costs vary significantly based on device complexity, but expect to invest 15-30% of your development budget in phases 2-4. This upfront investment typically saves 3-5x that amount in avoided manufacturing issues and delays.
What's the difference between design validation and process validation? Design validation confirms your device works as intended for users. Process validation ensures your manufacturing process consistently produces devices that meet specifications. Both are required for regulatory approval.
What happens if you skip process validation? Companies that skip process validation often experience inconsistent product quality, failed clinical trials due to device failures, expensive manufacturing troubleshooting, and delays in regulatory approval and market launch.
Related Reading: Building a Resilient Medical Device Supply Chain: Your Action Plan for Success
For medical device companies navigating today's complex manufacturing landscape, your medical device supply chain can make or break your path to market. Whether you're preparing for clinical builds or scaling to meet market demand, the actions you take today to evaluate and collaborate with suppliers directly impacts your regulatory success, product quality, commercial success and operational resilience tomorrow.
The manufacturing services experts at Veranex have guided hundreds of medical device companies through this critical transition. Whether you're wrestling with specifications, risk analysis, or manufacturing transfer strategy, experienced guidance can help you avoid costly missteps and accelerate your path to market. Learn more about our medical device contract manufacturing services or reach out to start a conversation about your specific manufacturing challenges.
Bill Croisetiere serves as Senior Director, Integrated Supply Chain & Operations at Veranex, bringing 34 years of extensive global experience and a profound internal drive for delivering successful results that align with client interests. His distinguished career, including two decades at Covidien, spans diverse management roles across manufacturing operations, supply chain, engineering, program management, IT, sales, and business development within global and private medical device, pharmaceutical, molding, and technology companies.
Based in Providence, Bill is a seasoned expert in critical areas such as manufacturing processes, sustaining and value engineering, product identification (UDI), advanced packaging systems, ERP implementation, and RF warehouse management solutions. This rich, multifaceted background provides him with a unique perspective to thoroughly analyze client needs. He excels at aligning business models with commercial and financial goals, ensuring that Veranex’s integrated supply chain strategies are optimized to support innovative product development and engineering projects from concept through to commercialization. His PMP and CSCP certifications further underscore his commitment to excellence in program and supply chain management.
Our approach to Quality Management ensures that we’re always speaking the same language.
2 min read
Anyone who works in medtech product development knows that surprises are a guarantee. That’s why it’s important to create stability and...
Behind many successful medical devices are design and engineering firms that provide the technical expertise, regulatory knowledge, and development...